Literature DB >> 3263829

Specific immune responses in Lyme borreliosis. Characterization of T cell and B cell responses to Borrelia burgdorferi.

R J Dattwyler1, D J Volkman, J J Halperin, B J Luft, J Thomas, M G Golightly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3263829     DOI： 10.1111/j.1749-6632.1988.tb31842.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  22 in total

Review 1.  Host-pathogen interactions in the immunopathogenesis of Lyme disease.

Authors:  L T Hu; M S Klempner
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

2.  Lyme borreliosis: host responses to Borrelia burgdorferi.

Authors:  A Szczepanski; J L Benach
Journal:  Microbiol Rev       Date:  1991-03

3.  Characterization of the heat shock response and identification of heat shock protein antigens of Borrelia burgdorferi.

Authors:  M M Carreiro; D C Laux; D R Nelson
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

4.  Immunogenic integral membrane proteins of Borrelia burgdorferi are lipoproteins.

Authors:  M E Brandt; B S Riley; J D Radolf; M V Norgard
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

5.  Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver.

Authors:  U E Schaible; S Gay; C Museteanu; M D Kramer; G Zimmer; K Eichmann; U Museteanu; M M Simon
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

Review 6.  Systematic review of the treatment of early Lyme disease.

Authors:  P S Loewen; C A Marra; F Marra
Journal:  Drugs       Date:  1999-02       Impact factor: 9.546

7.  Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo.

Authors:  R Wallich; C Brenner; M D Kramer; M M Simon
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo.

Authors:  J Alder; M Mitten; K Jarvis; P Gupta; J Clement
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

9.  Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses.

Authors:  A Krause; G R Burmester; A Rensing; C Schoerner; U E Schaible; M M Simon; P Herzer; M D Kramer; R Wallich
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

10.  Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice.

Authors:  U E Schaible; M D Kramer; K Eichmann; M Modolell; C Museteanu; M M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.